|
Name |
2-Methyl-1,5-heptadiene
|
Molecular Formula | C8H14 | |
IUPAC Name* |
(5E)-2-methylhepta-1,5-diene
|
|
SMILES |
C/C=C/CCC(=C)C
|
|
InChI |
InChI=1S/C8H14/c1-4-5-6-7-8(2)3/h4-5H,2,6-7H2,1,3H3/b5-4+
|
|
InChIKey |
LXKRFDPUBWVICN-SNAWJCMRSA-N
|
|
Synonyms |
2-METHYL-1,5-HEPTADIENE; 6766-54-7; 41044-63-7; trans-2-Methyl-1,5-heptadiene; (5E)-2-methylhepta-1,5-diene; (5E)-2-Methyl-1,5-heptadiene; 1,5-Heptadiene, 2-methyl-, (E)-; 2,6-dimethyl-1,5-hexadiene; (E)-2-methylhepta-1,5-diene; (5Z)-2-Methyl-1,5-heptadiene; 2-Methyl-1,5-heptadiene (c,t); 41044-64-8; ZINC1597080; MFCD00059240; (S)-(-)-METHYLP-TOLYLSULFOXIDE; T72820
|
|
CAS | 41044-63-7 | |
PubChem CID | 291987 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 110.2 | ALogp: | 3.3 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 8 | QED Weighted: | 0.486 |
Caco-2 Permeability: | -4.271 | MDCK Permeability: | 0.00002950 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.671 |
30% Bioavailability (F30%): | 0.887 |
Blood-Brain-Barrier Penetration (BBB): | 0.99 | Plasma Protein Binding (PPB): | 91.98% |
Volume Distribution (VD): | 4.389 | Fu: | 10.19% |
CYP1A2-inhibitor: | 0.676 | CYP1A2-substrate: | 0.714 |
CYP2C19-inhibitor: | 0.139 | CYP2C19-substrate: | 0.762 |
CYP2C9-inhibitor: | 0.024 | CYP2C9-substrate: | 0.873 |
CYP2D6-inhibitor: | 0.074 | CYP2D6-substrate: | 0.777 |
CYP3A4-inhibitor: | 0.022 | CYP3A4-substrate: | 0.193 |
Clearance (CL): | 7.766 | Half-life (T1/2): | 0.533 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.056 |
Drug-inuced Liver Injury (DILI): | 0.031 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.005 | Maximum Recommended Daily Dose: | 0.093 |
Skin Sensitization: | 0.623 | Carcinogencity: | 0.155 |
Eye Corrosion: | 0.989 | Eye Irritation: | 0.99 |
Respiratory Toxicity: | 0.042 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001683 | 0.387 | D03ZFG | 0.250 | ||||
ENC000453 | 0.385 | D0M1PQ | 0.205 | ||||
ENC001828 | 0.375 | D0R3QY | 0.158 | ||||
ENC001696 | 0.350 | D0Q9HF | 0.150 | ||||
ENC005738 | 0.316 | D0T3NY | 0.148 | ||||
ENC002142 | 0.306 | D05XQE | 0.141 | ||||
ENC001718 | 0.306 | D0H6VY | 0.140 | ||||
ENC001725 | 0.303 | D0Z5BC | 0.140 | ||||
ENC001684 | 0.300 | D0U5CE | 0.139 | ||||
ENC001642 | 0.275 | D03LGG | 0.139 |